A new study in the Journal of the National Cancer Institute found veterans taking statin drugs had a 9.4 percent cancer incidence compared to 13.2 percent for non-statin users.
Researchers say the findings support the hypothesis that statins may reduce the risk of cancer, in particular lung and colorectal cancers.